McLean M, Chow E, O'Sullivan B, Munro A, Leung P M, Loblaw D A, Panzarella T
Department of Radiation Oncology, Princess Margaret Hospital/University of Toronto, Ontario, Canada.
Radiother Oncol. 1998 Aug;48(2):209-11. doi: 10.1016/s0167-8140(98)00052-8.
Since 1989, 17 patients have undergone re-irradiation for locally recurrent nasopharyngeal cancer (NPC). The dose currently administered externally is 39.6 Gy in 36 fractions (BID) followed by an intracavitary boost (15-20 Gy). Disease persisted in five out of five patients treated palliatively. Eleven of 12 patients treated with curative intent achieved local control.
自1989年以来,17例局部复发性鼻咽癌(NPC)患者接受了再照射治疗。目前外部给予的剂量为39.6 Gy,分36次(每日两次),随后进行腔内加量照射(15 - 20 Gy)。5例接受姑息性治疗的患者中,有5例疾病持续存在。12例接受根治性治疗的患者中有11例实现了局部控制。